menu search

Why proqr therapeutics stock got slammed again monday

Analysts are notably more bearish on the company following unhappy news about its leading drug candidat...

February 14, 2022, 6:23 pm

Why proqr therapeutics stock got slammed again monday

Analysts are notably more bearish on the company following unhappy news about its leading drug candidat...

February 14, 2022, 6:23 pm

Proqr (prqr) plunges as lead drug fails in phase ii/iii study

ProQR (PRQR) lead candidate sepofarsen did not meet primary and secondary goals in phase II/III study....

February 14, 2022, 5:46 pm

Proqr (prqr) plunges as lead drug fails in phase ii/iii study

ProQR (PRQR) lead candidate sepofarsen did not meet primary and secondary goals in phase II/III study....

February 14, 2022, 5:46 pm

Proqr (prqr) plunges as lead drug fails in phase ii/iii study

ProQR (PRQR) lead candidate sepofarsen did not meet primary and secondary goals in phase II/III study....

February 14, 2022, 5:46 pm

5 short squeeze candidate to watch: aridis pharmaceuticals tops list, evgo, indonesia energy corp and more

Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move. A short squeeze can occur when a heavily s...

February 14, 2022, 10:40 am

5 short squeeze candidate to watch: aridis pharmaceuticals tops list, evgo, indonesia energy corp and more

Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move. A short squeeze can occur when a heavily s...

February 14, 2022, 10:40 am

5 short squeeze candidate to watch: aridis pharmaceuticals tops list, evgo, indonesia energy corp and more

Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move. A short squeeze can occur when a heavily s...

February 14, 2022, 10:40 am

Novavax says its covid-19 vaccine candidate had a 80% efficacy rate in teens

Shares of Novavax Inc. NVAX, -4.13% gained 2.5% in premarket trading on Friday, the day after the company said its experimental COVID-19 vaccine had a...

February 11, 2022, 8:42 am

Novavax says its covid-19 vaccine candidate had a 80% efficacy rate in teens

Shares of Novavax Inc. NVAX, -4.13% gained 2.5% in premarket trading on Friday, the day after the company said its experimental COVID-19 vaccine had a...

February 11, 2022, 8:42 am

Novavax says its covid-19 vaccine candidate had a 80% efficacy rate in teens

Shares of Novavax Inc. NVAX, -4.13% gained 2.5% in premarket trading on Friday, the day after the company said its experimental COVID-19 vaccine had a...

February 11, 2022, 8:42 am

Phathom pharma's digestive disease candidate meets primary goal in mid-stage study

Phathom Pharmaceuticals Inc PHAT reported topline results from the PHALCON-NERD Phase 2 study of vonoprazan as an on-demand therapy to relieve episod...

February 10, 2022, 10:02 am

Phathom pharma's digestive disease candidate meets primary goal in mid-stage study

Phathom Pharmaceuticals Inc PHAT reported topline results from the PHALCON-NERD Phase 2 study of vonoprazan as an on-demand therapy to relieve episod...

February 10, 2022, 10:02 am

Phathom pharma's digestive disease candidate meets primary goal in mid-stage study

Phathom Pharmaceuticals Inc PHAT reported topline results from the PHALCON-NERD Phase 2 study of vonoprazan as an on-demand therapy to relieve episod...

February 10, 2022, 10:02 am

Molecular partners, novartis submit emergency use authorization request for ensovibep for covid-19

Molecular Partners AG MOLN and its partner Novartis AG NVS, have requested FDA Emergency Use Authorization (EUA) for ensovibep, a DARPin antivira...

February 10, 2022, 7:13 am

Molecular partners, novartis submit emergency use authorization request for ensovibep for covid-19

Molecular Partners AG MOLN and its partner Novartis AG NVS, have requested FDA Emergency Use Authorization (EUA) for ensovibep, a DARPin antivira...

February 10, 2022, 7:13 am

Molecular partners, novartis submit emergency use authorization request for ensovibep for covid-19

Molecular Partners AG MOLN and its partner Novartis AG NVS, have requested FDA Emergency Use Authorization (EUA) for ensovibep, a DARPin antivira...

February 10, 2022, 7:13 am

Silence therapeutics posts first human data for cardiovascular candidate

Silence Therapeutics plc SLN showed that its RNAi technology could reduce a patient's lp(a) levels by 98% at a high dose. Get the Inside Access Trad...

February 9, 2022, 3:35 pm

Silence therapeutics posts first human data for cardiovascular candidate

Silence Therapeutics plc SLN showed that its RNAi technology could reduce a patient's lp(a) levels by 98% at a high dose. Get the Inside Access Trad...

February 9, 2022, 3:35 pm

Silence therapeutics posts first human data for cardiovascular candidate

Silence Therapeutics plc SLN showed that its RNAi technology could reduce a patient's lp(a) levels by 98% at a high dose. Get the Inside Access Trad...

February 9, 2022, 3:35 pm


Search within

Pages Search Results: